In pancreatic cancer, TRMT112 and WBSCR22 synergistically inhibit pancreatic cancer progression by repressing ISG15 transcription, which seems to support the possibility that TRMT112 is a tumor suppressor [106]. This evidence concerns the gene BUD23 and pancreatic neoplasm.